TITLE

Bilateral sequential lung transplantation for end stage septic lung disease

AUTHOR(S)
Hasan, A; Corris, P A; Healy, M; Wrightson, N; Gascoigne, A D; Waller, D A; Wilson, I; Hilton, C J; Gould, F K; Forty, J
PUB. DATE
May 1995
SOURCE
Thorax;May1995, Vol. 50 Issue 5, p565
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66014380

 

Related Articles

  • Heart and lung transplantation in patients with end stage lung disease. Penketh, Andrea; Higenbottam, Tim; Hakim, Moshsin; Wallwork, John // British Medical Journal (Clinical Research Edition);8/1/1987, Vol. 295 Issue 6593, p311 

    Examines the heart and lung transplantation in patients with end stage lung disease. Suitability of heart and lung transplantation in treating patients with end stage chronic lung disease; Indication of normal exercise tolerance among survivors; Improvements in lung function through heart and...

  • Anesthesia for lung transplantation. Miranda, Allen; Zink, Robert; McSweeney, Mary // Seminars in Cardiothoracic & Vascular Anesthesia;Sep2005, Vol. 9 Issue 3, p205 

    Lung transplantation is the only therapeutic option for more than 3,000 individuals in the United States with end-stage lung disease. Innovations in anesthetic and surgical techniques have expanded the indications for lung transplantation. Presently, the major limiting factor in the number of...

  • Polyomavirus in a Lung Transplant Patient. Jani, Jigna C.; Meihua Guo; Siddiqui, Noman H. // Archives of Pathology & Laboratory Medicine;Dec2004, Vol. 128 Issue 12, p1463 

    This article focuses on the treatment of polyomavirus in a lung transplant patient. A 51-year-old Asian woman with a history of systemic scleroderma underwent bilateral lung transplantation for end-stage lung disease. She was then put on cyclophosphamide as an immunosuppressant. Hematuria workup...

  • Lung Transplantation Triggered "Jackhammer Esophagus": A Case Report and Review of Literature. Khan, Mohammed Q.; Nizami, Imran Y.; Khan, Basha J.; Al-Ashgar, Hamad I. // Journal of Neurogastroenterology & Motility;Jul2013, Vol. 19 Issue 3, p390 

    A 19-years-old girl was referred for lung transplant due to end stage lung disease secondary to idiopathic bilateral bronchiectasis. Her routine pre lung transplant evaluation showed normal esophageal high-resolution manometry (HRM) and 24-hours impedance pH monitoring. Four weeks after the...

  • A review of the lung transplantation programme in Ireland 2005—2007. Bartosik, Waldemar; Egan, Jim J.; Soo, Alan; Remund, Kaspar F.; Nölke, Lars; McCarthy, James F.; Wood, Alfred E. // European Journal of Cardio-Thoracic Surgery;May2009, Vol. 35 Issue 5, p807 

    Abstract: Objective: Lung transplantation is a recognised surgical option for patients with end stage respiratory disease. We present data relating to the initiation of the Irish lung transplant programme in 2005. Methods: Seventeen patients: 7 male and 10 female have undergone lung...

  • Lung transplantation for cystic fibrosis. Aurora, Paul // Journal of the Royal Society of Medicine (Supplement);Jun2007, Vol. 100 Issue 47, p46 

    The article focuses on the selection criteria of lung transplant candidates for lung transplantation (LTx) as a treatment for adults and children with end-stage cystic fibrosis (CF) lung disease. Approximately 30% of 1700 lung transplantations are done for patients with CF lung disease. Among...

  • Outcome of lung transplantation in elderly recipients. Tomaszek, Sandra C.; Fibla, Juan J.; Dierkhising, Ross A.; Scott, John P.; Shen, Keh-Hsien R.; Wigle, Dennis A.; Cassivi, Stephen D. // European Journal of Cardio-Thoracic Surgery;May2011, Vol. 39 Issue 5, p726 

    Abstract: Objective: Lung transplantation is a standard treatment option for patients with end-stage lung disease. Lung transplantation in the elderly is controversial due to concerns over anticipated increased surgical risks, inferior long-term outcomes and proper stewardship in allocating...

  • Long-term outcome of lung transplantation for cystic fibrosis — Danish results. Bech, Bo; Pressler, Tanja; Iversen, Martin; Carlsen, Jørn; Milman, Nils; Eliasen, Kirsten; Perko, Mario; Arendrup, Henrik // European Journal of Cardio-Thoracic Surgery;Dec2004, Vol. 26 Issue 6, p1180 

    Abstract: Objective: Over the last decades improvements in medical therapies have delayed the progression of lung disease in cystic fibrosis (CF). However, lung disease is still the most common cause of premature death, and lung transplantation today is the only treatment for end-stage lung...

  • Transplantacija pluća u bolesnika sa cističnom fibrozom. Tješić-Drinković, Dorian; Tješić-Drinković, Duška // Paediatria Croatica;Apr-Jun2015, Vol. 59 Issue 2, p81 

    The rate of lung transplantation, the most aggressive therapy available for end-stage lung disease, is increasing and cystic fibrosis is one of the most frequent indications for the procedure, both in children and adults. The burdens of comorbidities related to the underlying cystic fibrosis are...

  • Live related donor lobar lung transplantation recipients surviving well over a decade: still an option in times of advanced donor management. Mohite, Prashant N.; Popov, Aron F.; Yacoub, Magdi H.; Simon, Andre R. // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue 1, p1 

    As waiting lists for lung transplantation are ever increasing, the number of organ donors is not able to keep pace with it. Living donor lobar lung transplantation is a source of organs which could be lifesaving in end-stage lung disease patients who cannot wait for cadaveric organs due to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics